Metformin 1000 mg	Metformin 1500 mg	IL-10	-1	-1	We found that there were no effects of serum IL-6, IL-10, or TNF-α between 1000 and 1500 mg treatments with metformin in type 2 diabetic patients
Metformin 1000 mg	Metformin 1500 mg	IL-10	-1	-1	We found that there were no effects of serum IL-6, IL-10, or TNF-α between 1000 and 1500 mg treatments with metformin
Metformin	Control	Monocyte chemoattractant protein-1	827	976	We found that metformin reduced the levels of IL-6 in blood and MCP-1 in urine, but increased IL-10 levels in blood of patients with type 2 diabetes.
Metformin	Control	Monocyte chemoattractant protein-1	1068	1211	Furthermore, compared to individual drug treatment, metformin significantly reduced the levels of serum IL-6 and TNF-α, as well as urine MCP-1.
Metformin 1000 mg	Metformin 1500 mg	Blood glucose 	-1	-1	Blood glucose (mmol/L) <TAB> 6.44 ± 0.96 <TAB> 91 <TAB> 6.27 ± 1.04 <TAB> 21 <TAB> 0.4684
Metformin	Control	Monocyte chemoattractant protein-1	8951	9085	We found that the levels of MCP-1 were significantly reduced in urine of metformin-treated patients as compared to non-metformin group
